Compare Interpace Diagnostics Group (PF4) vs. Competitors

0 Followers

Comparison Results

PF4

Interpace Diagnostics Group

€1.33

€33.39M

0.22

65.14%

―

Myriad Genetics

$3.19

$388.34M

-3.80

-39.95%

1 Buy

4 Hold

3 Sell

Hold

Veracyte

$44.04

$3.55B

31.81

28.57%

9 Buy

1 Hold

1 Sell

Moderate Buy

NeoGenomics

$17.37

$2.28B

-9.31

105.68%

5 Buy

3 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

PF4 vs NEO

xxxxxxxxxxxxx

Guardant Health

$164.92

$23.45B

-50.95

189.29%

21 Buy

0 Hold

0 Sell

Strong Buy

Castle Biosciences

$35.00

$1.08B

-53.92

59.96%

5 Buy

0 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

PF4 vs CSTL

xxxxxxxxxxxxx

Performance Comparison

DE:PF4

Interpace Diagnostics Group

6.40

2.52

65.14%

MYGN

Myriad Genetics

4.54

-3.52

-43.67%

VCYT

Veracyte

45.81

9.81

27.25%

NEO

NeoGenomics

18.47

9.37

102.97%

Guardant Health

177.80

114.96

182.94%

CSTL

Castle Biosciences

35.56

12.84

56.51%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >